Sort by
Refine Your Search
-
of the infrastructure. We envision that you will start with the easy assignments and then, as you learn and become more experienced, progress to increasingly difficult/qualified work. Qualifications The requirements
-
of complex brain processes. The prospective PhD candidate collects brain MSI data and develops novel machine learning methods in connection to generative models such as flow matching. Therefore, the doctoral
-
, the following are required: – Documented several years of experience in training, evaluating, and deploying machine learning models, including deep neural networks and relevant frameworks – Documented several
-
focus on innovative development and application of novel data-driven methods relying on machine learning, artificial intelligence, or other computational techniques. The applicant is expected to develop
-
on innovative development and application of novel data-driven methods relying on machine learning, artificial intelligence, or other computational techniques. The specific focus is on development and
-
grow into real impact. At the division of Data Science and AI , we develop data-driven methods and AI solutions that support intelligent decisions across society, advancing machine learning techniques
-
community of Digital Research Engineers. The offices also host computer infrastructure and machine learning/data science/research data management experts, who develop, build, and manage the local and national
-
biology and genetics. Experience using Git for version control. Ability to quickly learn new skills. Experience working in a Unix/Linux environment. Excellent verbal and written English skills. We
-
-performance computing. SLU provides access to extensive datasets that can be used to develop machine learning methods and automated analyses relevant to the position. Long-term datasets are available from, i.a
-
modeling, machine learning, and AI techniques applied to biomedical data is a plus. Clinical Proteomics: Experience with clinical trial data, real-world evidence (RWE), and biomarker-driven trial designs is